Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine

Business Insider

Published

· *Novavax shares leaped as much as 13.3% on Friday after finalizing a deal with the UK to supply 60 million doses of its potential coronavirus vaccine.*
· *The biotech company didn't reveal how much the UK paid for the doses.*
· *The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine,...

Full Article